Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

Topical spironolactone works better than topical finasteride for hair loss.

Cedrol nanoemulsions effectively treat hair loss by promoting hair growth and reducing DHT levels safely.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Apremilast improved symptoms in patients with severe skin conditions.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Glucocorticoid treatment lowered androgen levels but didn't improve hirsutism or ovulation and caused weight gain.

Allopregnanolone, a progesterone metabolite, helps reduce restraint effects on behavior.

The levonorgestrel intrauterine device for heavy periods may cause acne, hair loss, and excess hair growth.

Combining injections with lotion is more effective for hair regrowth in alopecia areata than using the lotion alone.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

The new gel for hair loss is safe, effective, and reduces side effects.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

The serum improves hair growth and scalp health.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

DMSO-liposomes improve finasteride delivery for hair loss treatment.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

A new topical treatment for hair loss is effective and safe with faster results.